Impact of Linked Color Imaging on Sessile Serrated Lesion Miss Rate

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45+
SponsorNanfang Hospital, Southern Medical University

About this trial

This prospective, multicenter randomized controlled trial aimed to investigate whether linked color imaging (LCI) could reduce the miss rate of sessile serrated lesions (SSLs) during tandem colonoscopy compared with conventional white-light imaging (WLI).

Eligibility criteria

Qualifiers

Subjects aged ≥45 years, regardless of gender;

Subjects undergoing screening colonoscopy;

Subjects with no prior colonoscopy;

Voluntarily provide written informed consent.

Disqualifiers

Subjects unable to cooperate with or tolerate colonoscopy;

Subjects with inflammatory bowel disease;

Known or highly suspected colorectal obstruction;

History of colorectal surgery;

Trial design

Treatments tested in this trial

  • WLI Then LCI Withdrawal
  • LCI Then WLI Withdrawal

Treatment groups

2,072 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Nanfang Hospital, Southern Medical University

Lead sponsor

Shunde First People's Hospital of Foshan

Collaborator

ZhuHai Hospital

Collaborator

Jiangmen Central Hospital

Collaborator

Yangjiang People's Hospital

Collaborator

Zhongshan Guzhen People's Hospital

Collaborator

Sihui Wanlong Hospital

Collaborator

The Third People's Hospital of Huizhou

Collaborator

Longgang District People's Hospital of Shenzhen

Collaborator

Suixi People's Hospital of Zhanjiang

Collaborator